|
|||||
|
|
Phase 2 trial of neoadjuvant bevacizumab plus pemetrexed and carboplatin in patients with unresectable stage III lung adenocarcinoma (GASTO 1001) |
|
| Authors: | Jian Li MD Qian‐Wen Liu MD Qun‐Ai Huang Bao‐Xiao Wang MD |
| Affiliation: | 1. Department of Ultrasound, Sun Yat‐sen University Cancer Center;2. State Key Laboratory of Oncology in South China;3. Collaborative Innovation Center for Cancer Medicine, Guangzhou, China;4. Department of Thoracic Surgery, Sun Yat‐sen University Cancer Center;5. Department of Thyroid and Breast Surgery, The Third Affiliated Hospital of Sun Yat‐sen University, Guangzhou, China;6. Breast Tumor Center, Sun Yat‐sen Memorial Hospital;7. Sun Yat‐sen University, Guangzhou, China |
| Abstract: | |
| Keywords: | bevacizumab locally advanced neoadjuvant chemotherapy nonsmall cell lung cancer surgery |